Researchers at the University Hospital Basel postulate that by quantifying erythrocyte-associated HIV-1, it may be possible to predict the likelihood of impending virological failure. Their research published in The Lancet June 29, 2002 tested 82 patients with chronic HIV-1 infection for the presence of circulating pools of the virus associated with erythrocytes, plasma and white cells. They suggest that current models of viral dynamics in HIV-1 infection may need to be adjusted in view of this so-far unrecognized viral pool.

Scientists from Lund University, Malmo have published the results of a12-year prospective follow-up study of adult diabetics. The findings, published in the June 2002 issue of Diabetes, show that islet cell antibodies, but not GADA or IA-2 antibodies, which developed after diagnosis in roughly 5% of the originally islet cell antibody-negative, mostly overweight patients, predicted a decline in beta-cell function. They suggest repeated islet antibody testing beginning at diagnosis in patients with adult-onset diabetes. This testing strategy can also be supported with a primary screen for GADA followed by a second test for IA-2 antibodies in GADA-positive patients with low GADA levels "to improve the prediction of a fast progression to beta-cell failure."